Beneficial effects of integrin αvβ3-blocking RGD peptides in early but not late phase of experimental glomerulonephritis.

Kerstin Amann*, Christian S. Haas, Julian Schüssler, Christoph Daniel, Andrea Hartner, Harald O. Schöcklmann

*Corresponding author for this work
9 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Beneficial effects of integrin αvβ3-blocking RGD peptides in early but not late phase of experimental glomerulonephritis.'. Together they form a unique fingerprint.

Medicine & Life Sciences